At PDA/FDA Joint Regulatory Conference 2026, PCI Pharma's Bassler details how a QMS overhaul turned an FDA 483 into stronger quality culture.
News|Articles|October 2, 2003
- Pharmaceutical Technology-10-02-2003
- Volume 27
- Issue 10
GMP Update: Reducing Obstacles to Innovation
Author(s)Jill Wechsler
FDA offers new policies to encourage modern manufacturing approaches and automated systems, to simplify postapproval changes, and to avoid problems with sterile products.
Advertisement
Articles in this issue
almost 23 years ago
Designing a New Drug Packagealmost 23 years ago
Filling the Void: PAT in a Connected Manufacturing Environmentalmost 23 years ago
Process Analytical Technology Concepts and Principlesalmost 23 years ago
October 2003almost 23 years ago
Outsourcing is Front Page News in 2003almost 23 years ago
October 2003almost 23 years ago
In the Spotlight - NovemberAdvertisement
Related to this article
Advertisement
Advertisement